Stocks股票 / Health Care / ARWR
Arrowhead Pharmaceuticals · Health Care
ARWR US listed · USD美股 · 美元
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California.Arrowhead Pharmaceuticals, Inc. 是一家公开交易的生物制药公司，总部位于加利福尼亚州帕萨迪纳。
Mid cap中盘 · $10B
Speculative / unprofitable投机／未盈利
Health Care
S&P 400标普400中盘
$71.65
-$2.65 · -3.57%
52w low52周低 $14.03high高 $88.58
Constructive — building a base建设性 — 正在筑底
Daily low forming, but the bigger trend is still bearish. Small size only; stop below 71.38.日线低点正在形成，但大趋势仍偏空。只适合小仓位；止损设于 71.38 下方。
Engine read引擎解读 · 2026-07-21
Price chart价格图表
daily · interactive日线 · 可交互
Open in Terminal打开终端 ↗
Loading chart…图表加载中…
The interactive chart could not load here.互动图表暂时无法在此加载。
Open the live chart in Terminal在终端中打开实时图表 ↗
Candles, volume and moving averages — pan and zoom inside the chart.蜡烛图、成交量与均线 — 图内可缩放拖动。
MMastermind Terminal — live & interactiveMastermind 终端 — 实时互动 ↗
Technicals技术面
daily bars日线数据 · 2026-07-21
Momentum (RSI 14)动量（RSI 14）
39
Depressed偏低
vs 50-day average相对50日均线
-7.2% below下方
Below trend跌破趋势
vs 200-day average相对200日均线
+13.8% above上方
Long trend up长期向上
Volatility波动率
23th percentile第23百分位
These readings feed the stance at the top — one source per number, refreshed nightly.以上读数构成页首的引擎立场 — 每个数字只有一个来源，每晚更新。
Earnings财务业绩
next report下次财报 2026-08-0617days to go天后公布
Estimates being raised — 2 analysts预期上调 — 2 位分析师
Valuation估值
Expensive vs sector相对行业偏贵| Multiple指标 | ARWR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 17.32x | 3.44 | |
| P/S市销率 | 11.87x | 2.97 | |
| Earnings yield盈利收益率 | -0.02% | 2.72 | |
| FCF yield自由现金流收益率 | 1.59% | 4.00 | |
| EV/EBITDA企业价值/EBITDA | 79.78x | 18.18 | |
| P/FCF市值/自由现金流 | 62.75x | 22.08 |
"Cheaper than" = share of sector peers trading richer on that multiple.「相对便宜」= 行业中该指标估值更高的同行占比。
Financials财务数据
fiscal years财年Revenue营业收入
5-yr growth5年复合增速 56.6%
Earnings per share每股收益
Free cash flow自由现金流
Operating margin营业利润率
11.9%
Net margin净利率
-0.2%
FCF margin自由现金流利润率
21.6%
Balance-sheet quality财务体质 4/7
Bankruptcy risk: safe zone破产风险：安全区
Return on equity股本回报率 -0%
Clean稳健
Leverage杠杆
Net debt / EBITDA净债务/EBITDA-1.88
Current ratio流动比率4.86
Capital allocation资本配置
Stock-based comp股权薪酬$63.4M
Share count change (1y)股数变化（1年）+9.4%
Why is it moving为何波动
6 checks · nightly六项检查 · 每晚
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed -28.2%空头仓位变动 -28.2%
Technical技术面
ARWR weekly MACD crossed downARWR 周线MACD下穿
Ownership & smart money持仓与聪明钱
13FInsider activity:内部人动向： -$34.9M net (0 buyers, 8 sellers)-$34.9M 净值（0 买家，8 卖家）
Concentrated ownership集中持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | As of截至 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 0.7% | 2026-03-31 |
| RTW Investments | B | Holding持有 | 0.4% | 2026-03-31 |
Signal history信号历史
engine events引擎事件
BOTTOMING → UNCONFIRMED TURN筑底中 → 未确认转向
HIGH-RISK · NIMBLE ONLY. A daily bottoming setup is forming (swing low in, momentum turned up) — but the higher timeframes haven't confirmed it: the bigger picture is still bearish (weekly momentum just crossed down; 3-day crossed down). This is an UNCONFIRMED TURN, not a confirmed buy. Weekly confirmation lags price, so this exact reading covers BOTH bounces that fail AND the first leg of a genuine new cycle — you can't tell which in real time, so treat it as a risk/size signal, not a direction call. Measured: weekly-unconfirmed bottoming setups held the low ~49% of the time vs ~68% once the weekly turns up高风险 · 仅限灵活操作。正在形成日线筑底形态（摆动低点已现、动量转向上行）——但更高周期尚未确认：大局仍偏空（周线动量刚刚向下交叉；3 日线向下交叉）。这是「未确认转向」，并非已确认的买入。周线确认滞后于价格，因此同样的读数既涵盖最终失败的反弹，也涵盖真正新周期的第一段——实时无法判定属于哪一种，故应将其视为风险/仓位信号，而非方向判断。实测：周线未确认的筑底形态约 49% 守住低点，周线转向后升至约 68%
Jul 10, 2026
ARWR weekly MACD crossed downARWR 周线MACD下穿
The weekly MACD histogram turned negative — the slower, less-whippy momentum read.周线MACD柱状图转负 — 更慢、更少来回的动量信号。
Jul 10, 2026
ARWR daily MACD crossed downARWR 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $76.40.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$76.40。
Jul 9, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 8, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 6, 2026
BUY ZONE → BOTTOMING买入区 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
NEARING A LOW → BUY ZONE接近低点 → 买入区
BUY买入
Jul 2, 2026
ARWR made a new 52-week highARWR 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $83.99.价格创出52周新高 — 全市场关注的动量/趋势极值。$83.99。
Jul 1, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jun 30, 2026
BUY ZONE → UPTREND买入区 → 上涨趋势
HOLD持有
Showing the last 15 of显示最近15条，共 241 signals条信号
Company profile公司档案
Arrowhead Pharmaceuticals, Inc. is a publicly traded biopharmaceutical company based in Pasadena, California.Arrowhead Pharmaceuticals, Inc. 是一家公开交易的生物制药公司，总部位于加利福尼亚州帕萨迪纳。
Style DNA — how it trades vs the market风格基因 — 相对市场的交易特征
Value价值
Below market低于市场
Quality质量
Above market高于市场
Investment资本投入
Below market低于市场
Low volatility低波动
Below market低于市场
Low market beta低市场敏感度
Below market低于市场
Earnings quality盈利质量
Below market低于市场
Short interest空头兴趣
Below market低于市场
The whole US universe — S&P 1500 and Russell 2000 — read nightly.覆盖标普1500与罗素2000全部成分股 — 每晚更新解读。
Signals, options positioning, smart-money moves and factor DNA — the same engine that wrote this page covers 2,700+ US stocks.信号、期权持仓、聪明钱动向与因子基因 — 撰写本页的引擎覆盖2700多只美股。
Statistics — full detail统计数据 — 完整明细
Valuation vs sector估值对比行业
| Multiple指标 | This stock本股 | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| Price / Book市净率 | 17.3× | 3.4× | 6% |
| Price / Sales市销率 | 11.9× | 3.0× | 9% |
| EV / EBITDAEV/EBITDA | 79.8× | 18.2× | 4% |
| Earnings yield盈利收益率 | -0.0% | 2.7% | 25% |
| Free-cash-flow yield自由现金流收益率 | 1.8% | 5.5% | 15% |
Relative strength相对强度
vs market, 1 month相对大盘（1个月）
98/100 — stronger than most强于多数
vs market, 3 months相对大盘（3个月）
52/100 — middle of the pack居中
vs market, 6 months相对大盘（6个月）
60/100 — middle of the pack居中
vs market, 12 months相对大盘（12个月）
98/100 — stronger than most强于多数
Rank in sector行业内排名
#2 / 165
0–100 percentile of total return vs all covered stocks.总回报在全部覆盖股票中的百分位（0–100）。
Price history价格历史
| Period周期 | This stock本股 | S&P 500标普500 |
|---|---|---|
| 1 Week近1周 | -3.3% | -0.9% |
| 1 Month近1月 | -12.4% | -0.6% |
| 3 Months近3月 | +0.8% | +5.4% |
| 6 Months近6月 | +6.0% | +8.6% |
| Year to date年初至今 | +5.7% | +8.9% |
| 1 Year近1年 | +327.5% | +19.2% |
| 3 Years近3年 | +98.6% | +69.9% |
Trading information交易信息
Beta vs market贝塔
1.51
Volatility rank波动率分位
23th pctile
Short interest空头占比
6.1% of float
Market cap市值
$10B
EPS (trailing)每股收益
$-0.01
Off 52-week high距52周高点
-17.6%
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Financials — full detail财务数据 — 完整明细
Multi-year record多年财务记录
| 20202020 | 20212021 | 20222022 | 20232023 | 20242024 | 20252025 | |
|---|---|---|---|---|---|---|
| Revenue营业收入 | $88M | $138M | $243M | $241M | $4M | $829M |
| EPS每股收益 | $-0.84 | $-1.36 | $-1.67 | $-1.92 | $-5.00 | $-0.01 |
| Free cash flow自由现金流 | $-107M | $148M | $-189M | $-331M | $-604M | $157M |
| Gross margin毛利率 | — | — | — | — | — | — |
| Net margin净利率 | -96.1% | -101.9% | -72.4% | -85.3% | -16882.4% | -0.2% |
| FCF margin自由现金流利润率 | -122.0% | 106.8% | -77.7% | -137.3% | -17018.3% | 18.9% |
Latest fiscal year最近财年
Revenue (FY)营业收入（财年）
$829M
Net income净利润
$-2M
Operating cash flow经营现金流
$180M
Total assets总资产
$1.6B
Shareholder equity股东权益
$568M
Shares outstanding总股本
0.14B
Returns & growth回报与增长
Return on equity股本回报率
-0.3%
Return on assets资产回报率
-0.1%
Asset growth资产增速
+58.3%
Accounting quality checks会计质量检查
- Earnings quality: earnings cash-backed盈利质量：盈利有现金支撑
- Working capital: inventory & receivables lean vs sales营运资本：存货与应收相对销售保持精简
- Capital discipline: share count +32.6% over 6 years (dilution)资本纪律：股本 6 年增加 32.6%（稀释）
- Balance sheet: Altman Z 6.27 — safe zone资产负债表：Altman Z 6.27——安全区
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Technicals — full detail技术面 — 完整明细
Indicator readings指标读数
RSI (14-day)RSI（14日）
39
RSI (2-day)RSI（2日）
32
vs 20-day average相对20日均线
-9.4%
vs 50-day average相对50日均线
-7.2%
vs 200-day average相对200日均线
+13.8%
Golden cross (50>200)金叉（50>200）
in effect生效中
MACDMACD
below signal位于信号线下方
Timeframe alignment多周期共振
Daily日线
momentum down动能向下
3-day3日线
momentum down — fresh downturn动能向下——刚刚转弱
Weekly周线
momentum down — fresh downturn动能向下——刚刚转弱
When daily through monthly point the same way, moves carry further.当日线到月线方向一致时，行情往往更有延续性。
Volatility regime波动状态
Range width percentile波幅宽度分位
63/100
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Earnings — full detail财务业绩 — 完整明细
Estimate revisions预期修正
Analysts covering覆盖分析师
2
Estimate direction预期调整方向
mostly raising多数上调
Estimate change, 90 days预期变化（90天）
-5.8%
Net upgrades, 30 days净上调（30天）
+2
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Ownership — full detail持仓 — 完整明细
Tracked funds holding it跟踪基金持仓
| Fund基金 | Grade评级 | Latest move最新动作 | % of book组合占比 | Position市值 |
|---|---|---|---|---|
| Baker Bros. Advisors | A | Holding持有 | 0.7% | $125M |
| RTW Investments | B | Holding持有 | 0.4% | $37M |
Fund positioning基金持仓概览
Tracked funds in the name持有该股的跟踪基金
2
Buying vs selling买入vs卖出
0 : 0
Quarterly trend季度趋势
{'direction': 'distributing', 'n_quarters': 5, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2025-06-30', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2025-08-14', 'holders_series': [1, 1, 2, 2, 0]}{'direction': 'distributing', 'n_quarters': 5, 'holders_first': 1, 'holders_last': 0, 'holders_delta': -1, 'value_change_pct': -100.0, 'from_period': '2025-06-30', 'to_period': '2026-06-30', 'available_on': '', 'available_on_first': '2025-08-14', 'holders_series': [1, 1, 2, 2, 0]}
Insiders & shorts内部人与空头
Insider net buying (6 months)内部人净买入（6个月）
-$34.9M
Insider buyers vs sellers内部人买家vs卖家
0 : 8
Short interest空头占流通盘
6.1%
Days to cover回补天数
2.2
Short interest change空头变化
-28.2%
Recent fund flows近期基金流向
SPDR S&P BiotechSPDR S&P Biotech
trimming减持
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。
Seasonality — full detail季节性 — 完整明细
Strongest month最强月份
Jan · 100%
Weakest month最弱月份
Feb · 33%
Month by month逐月统计
| Month月份 | Closed higher收涨占比 | Median move中位涨跌 | Years年数 |
|---|---|---|---|
| Jan1月 | 100% | +6.7% | 3 |
| Feb2月 | 33% | -3.9% | 3 |
| Mar3月 | 33% | -9.3% | 3 |
| Apr4月 | 67% | +13.1% | 3 |
| May5月 | 100% | +7.0% | 3 |
| Jun6月 | 75% | +5.4% | 4 |
| Jul7月 | 50% | +2.7% | 4 |
| Aug8月 | 33% | -16.8% | 3 |
| Sep9月 | 33% | -2.3% | 3 |
| Oct10月 | 33% | -0.0% | 3 |
| Nov11月 | 67% | +26.1% | 3 |
| Dec12月 | 67% | +25.2% | 3 |
History is a tendency, not a promise — small samples wobble.历史规律只是倾向而非保证 — 样本少时波动大。
Research context only — refreshed nightly. Not investment advice.仅供研究参考 — 每晚更新，不构成投资建议。